Haleon plc (HLN) Stock Analysis

Haleon plc (HLN) is a publicly traded company in the HEALTHCARE sector. It trades at $8.71, carries a market capitalization of $39.10B, a price-to-earnings ratio of 17.68, a dividend yield of 0.02%. This page summarizes the public market data, fundamentals, and frequently asked questions for HLN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

• Price: $8.71
• Market Cap: $39.10B
• P/E Ratio: 17.68
• EPS: $0.50
• Dividend Yield: 0.02%
• 52-Week High: $11.13
• 52-Week Low: $8.60

Market Sentiment

Haleon plc currently has a Neutral sentiment score of -0.08.

About Haleon plc

None

GNG Research Analysis

GNG Research scores Haleon plc (HLN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for HLN.

Frequently Asked Questions

What is HLN's current dividend yield?

Haleon plc (HLN) has a current dividend yield of 0.02%.

Does HLN pay dividends?

Yes, Haleon plc pays dividends with a current yield of 0.02%.

What is HLN's P/E ratio?

Haleon plc has a price-to-earnings (P/E) ratio of 17.68.

What is HLN's market cap?

Haleon plc (HLN) has a market capitalization of $39.10B with a current stock price of $8.71.